For ER+ breast cancer, the selection criteria revealed 8 cell types: iCAF, myCAF, cancer luminal A, macrophages, ACKR1+ endothelial cells, differentiated PVLs, CD4+ T cells, and CD8+ T cells (8×8=64 possible source/target cell combinations). This evidence concerns the gene CD8A and breast carcinoma.